Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2016 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Other Working Capital Changes of -$89000.0 for Q1 2025, up 29.37% year-over-year from -$68797.5 in Q1 2024, and up 31.01% quarter-over-quarter from -$129000.0 in Q4 2024.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Other Working Capital Changes for 6 consecutive years, with -$89000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Other Working Capital Changes rose 29.37% year-over-year to -$89000.0; the TTM figure through Dec 2025 stood at -$89000.0 (up 82.62% YoY), while the FY2025 annual figure was -$89000.0, up 82.62% from the prior year.
- Other Working Capital Changes improved to -$89000.0 in Q1 2025 per WHWK's latest filing, from -$129000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.1 million in Q3 2022 and bottomed at -$1.7 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$352352.9 across 5 years, with a median of -$179000.0 in 2024.
- Annual changes were most pronounced in 2021 — Other Working Capital Changes surged 84.31% — and 2022, when it tumbled 1412.5%.
- Whitehawk Therapeutics' Other Working Capital Changes stood at -$8000.0 in 2021, then sank by 1412.5% to -$121000.0 in 2022, then dropped by 4.96% to -$127000.0 in 2023, then slipped by 1.57% to -$129000.0 in 2024, then soared by 31.01% to -$89000.0 in 2025.
- Business Quant data shows WHWK's Other Working Capital Changes at -$89000.0 in Q1 2025, -$129000.0 in Q4 2024, and -$129000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Whitehawk Therapeutics | 377.13 Mn | 377.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -755,000.00 |
| Jun 30, 2026 | -755,000.00 |
| Mar 31, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Dec 31, 2025 | 523,000.00 |
| Dec 31, 2025 | 523,000.00 |
| Sep 30, 2025 | 817,000.00 |
| Sep 30, 2025 | 817,000.00 |
| Jun 30, 2025 | -141,000.00 |
| Jun 30, 2025 | -141,000.00 |
| Mar 31, 2025 | -765,000.00 |
| Mar 31, 2025 | -765,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Sep 30, 2024 | -179,000.00 |
| Sep 30, 2024 | -179,000.00 |
| Jun 30, 2024 | -1.47 Mn |
| Jun 30, 2024 | -1.47 Mn |
| Mar 31, 2024 | -953,000.00 |
| Mar 31, 2024 | -953,000.00 |